Q2 FY2026 · ended Dec 31, 2025 · Revenue $65.63B, +18.8% YoY · Filed Feb 5, 2026
Cardinal Health, Inc. (CAH) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q2 of fiscal 2026, the quarter ended Dec 31, 2025, it reported revenue of $65.6 billion and net income of $467.0 million. Free cash flow was $555.0 million. As of Jun 30, 2026 it held $4.9 billion in cash and investments and $9.9 billion in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- CAH (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- OH
- Headquarters
- Dublin, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 721371
- Former names
- CARDINAL HEALTH INC (until Nov 5, 2026); CARDINAL DISTRIBUTION INC (until Feb 17, 1994)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
Q4 FY2025 Jun 30, 2025 |
Q3 FY2025 Mar 31, 2025 |
Q2 FY2025 Dec 31, 2024 |
|---|---|---|---|---|---|
| Revenue | $65.6B | $64.0B | $60.2B | $54.9B | $55.3B |
| Operating income | $707.0M | $668.0M | $428.0M | $730.0M | $549.0M |
| Net income | $467.0M | $450.0M | $239.0M | $506.0M | $400.0M |
| Diluted EPS | $1.97 | $1.88 | $1.00 | $2.10 | $1.65 |
| Operating cash flow | $686.0M | $973.0M | $1.5B | $2.9B | -$396.0M |
| Free cash flow | $555.0M | $865.0M | $1.3B | $2.8B | -$495.0M |
| Total assets | $58.1B | $55.2B | $53.1B | $49.9B | $47.0B |
| Stockholders' equity | -$2.9B | -$2.9B | -$2.8B | -$2.9B | -$3.0B |
| Cash and investments | $2.8B | $4.6B | $3.9B | $3.3B | $3.8B |
| Total debt | $9.0B | $9.0B | $9.3B | $7.7B | $7.6B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2026 | Oct 1, 2026 |
| ARS | Annual report to shareholders | Sep 21, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
All 1002 Cardinal Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.